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acid levels but caused downregulation of Slc22a1 (Oct1), Slc22a6 (Oat1), Slc22a19 (Oat5), and -Slc22a12
(Urat1) at mRNA level. In contrast, Slc22a4 mRNA (Octn1) was upregulated. On protein level, NH4Cl
increased Octn1 (after 7 days) and Urat1 (after 2 days) abundance and decreased Oat1 (after 2 days)
and Urat1 (after 7 days). Oxonic acid had no impact on protein abundance of any of the transporters
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Abstract
Introduction: The kidneys play a central role in eliminating metabolic waste products and 
drugs through transporter-mediated excretion along the proximal tubule. This task is mostly 
achieved through a variety of transporters from the solute carrier family 22 (SLC22) family of 
organic cation and anion transporters. Metabolic acidosis modulates metabolic and renal 
functions and also affects the clearance of metabolites and drugs from the body. We had pre-
viously shown that induction of metabolic acidosis in mice alters a large set of transcripts, 
among them also many transporters including transporters from the Slc22 family. Objective: 
Here we further investigated the impact of acidosis on Slc22 family members. Methods: Met-
abolic acidosis was induced for 2 or 7 days with NH4Cl, some animals also received the uricase 
inhibitor oxonic acid for comparison. Expression of transporters was studied by qPCR and im-
munoblotting. Results: NH4Cl induced no significant changes in plasma or urine uric acid 
levels but caused downregulation of Slc22a1 (Oct1), Slc22a6 (Oat1), Slc22a19 (Oat5), and 
 Slc22a12 (Urat1) at mRNA level. In contrast, Slc22a4 mRNA (Octn1) was upregulated. On protein 
level, NH4Cl increased Octn1 (after 7 days) and Urat1 (after 2 days) abundance and decreased 
Oat1 (after 2 days) and Urat1 (after 7 days). Oxonic acid had no impact on protein abundance 
of any of the transporters tested. Conclusion: In summary, metabolic acidosis alters expression 
of several transporters involved in renal excretion of metabolic waste products and drugs. This 
may have implications for drug kinetics and clearance of waste metabolites.
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Introduction
The renal proximal tubule plays a key role in eliminating endogenous metabolic waste 
products as well as in the excretion of water-soluble exogenous drugs and their metabolites. 
Various members of the solute carrier transporter family 22 (SLC22) contribute to this important 
task. They belong to at least 2 subgroups of transporters, organic anion transporters (OAT) and 
organic cation transporter (OCT; [1, 2]). Several OAT and OCT transporters are expressed in 
mammalian kidney and contribute to the excretion of organic anions and cations including uric 
acid. OAT and OCT transporters are expressed mainly in the proximal tubule and are located on 
either the luminal (apical) or basolateral membrane, thereby mediating uptake from/release 
into blood and reabsorption from/excretion into urine of various substrates. Major substrates of these transporters include para-amino hippurate, α-ketoglutarate, and urate as well as a 
plethora of cationic or anionic drugs [2]. Among these transporters, OAT1 (SLC22A6) and OCT1 
(SLC22A1) are localized at the basolateral site, whereas OCTN1 (SLC22A4), URAT1 (SLC22A12), 
and OAT5 (SLC22A10) are expressed at the luminal site of proximal tubule cells [2].
Previously, we had performed a genome-wide transcriptome analysis of mouse kidney 
after 2 and 7 metabolic acidosis induced by NH4Cl-supplementation to drinking water [3]. 
Surprisingly, we found a large number (> 3,000) of transcripts to be regulated including > 100 
members of the solute carrier family (SLC) highlighting the importance of transport processes 
in the kidney and the major impact of acidosis. Among the SLC subfamilies, we found members 
of the SLC22 family of organic anion and cation transporters to be highly represented with 5 
transporters being up- or downregulated during NH4Cl treatment [3]. Similarly, Gaowa et al. 
[4] showed in acutely acidotic rats (after 2 days of NH4Cl supplementation) that Oat3 was 
reduced while Oat1 and Oct1 remained unaffected [4].
The aim of the current study was to further study this regulation of Slc22 transporters by 
NH4Cl-induced metabolic acidosis. Our results demonstrate distinct patterns of regulation of 
several major representatives of this important Slc family.
Methods
Animals
All experiments were performed on 12 weeks old C57BL/6J male mice. All experiments 
were performed according to Swiss Animal Welfare laws and approved by the local veter-
inary authority (Veterinäramt Zürich).
Metabolic Cages
To induce metabolic acidosis C57BL/6J mice were given 0.28 M NH4Cl/2% sucrose in 
drinking water for 2 or 7 days. The control group received only 2% sucrose in drinking water 
for 7 days as described previously [3].
One group of mice received the uricase inhibitor oxonic acid (2%) added to drinking 
water during the entire period of the experiment as described previously [5].
Each group consisted of 5 animals for each time point and treatment. Forty-eight hour prior 
sacrificing mice were housed in metabolic cages and had free access to standard mouse chow 
and drinking water ad libitum. Daily chow, water intake, and body weights were measured, and 
urine was collected under mineral oil. At the end of experiment, mice were anesthetized with 
ketamine-xylazine, and heparinised mixed arterial-venous blood was collected and analyzed 
immediately for pH, blood gases, and electrolytes on a Radiometer ABL 800 (Radiometer, Copen-
hagen, Denmark) blood gas analyzer. Serum was collected and frozen until further analysis. Both 
kidneys were harvested and rapidly frozen in liquid nitrogen and stored at –80  ° C.
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Urinary pH was measured using a pH microelectrode (691 pH Meter, Metroholm). Urinary 
creatinine was measured by the Jaffe method [6]. Ammonium in urine was measured by the 
method of Berthelot [7]. Urinary and serum phosphate was measured using a commercial kit 
(Sigma Diagnostics, Munich, Germany). Serum and urine uric acid were measured using a 
colorimetric test according to the manufacturers protocol (BioAssay Systems, Hayward, CA, 
USA). Urinary electrolytes (Na+, K+, Ca2+, Mg2+, Cl–, SO4
2–) were measured by ion chromatog-
raphy (Metrohm ion chromatograph, Herisau, Switzerland).
RNA Extraction and Reverse Transcription
Kidneys were harvested and rapidly frozen in liquid nitrogen. Snap-frozen kidneys (5 
kidneys for each condition) were homogenized in RLT-Buffer (Qiagen, Basel, Switzerland) supplemented with β-mercaptoethanol to a final concentration of 1%. Total RNA was 
extracted from 200 µL aliquots of each homogenized sample using the RNeasy Mini Kit 
(Qiagen) according to the manufacturer’s instructions. Quality and concentration of the 
isolated RNA preparations were analyzed by the ND-1000 spectrophotometer (NanoDrop 
Technologies). Total RNA samples were stored at –80  ° C. Each RNA sample was diluted to 100 
ng/µL and 3 µL used as a template for reverse transcription using the TaqMan Reverse Tran-
scription Kit (Applied Biosystems, Forter City, CA, USA). For reverse transcription, 300 ng of 
RNA template were diluted in a 40-µL reaction mix that contained (final concentrations) RT 
buffer (1×), MgCl2 (5.5 mM), random hexamers (2.5 µM), RNase inhibitor (0.4 U/µL), the multi-
scribe reverse transcriptase enzyme (1.25 U/µL), dNTP mix (500 µM each), and RNase-free 
water.
Quantitative Real-Time PCR
Semi-quantitative real-time qRT-PCR was performed on the ABI PRISM 7700 Sequence 
Detection System (Applied Biosystems). Primers for all genes of interest were designed using 
Primer Express software from Applied Biosystems (Table 1). Primers were chosen to result 
in amplicons no longer than 150 bp spanning intron-exon boundaries to exclude genomic 
DNA contamination. The specificity of all primers was first tested on mRNA derived from 
kidney and always resulted in a single product of the expected size (data not shown). Probes were labeled with the reporter dye FAM at the 5′ end and the quencher dye TAMRA at the 3′ 
end (Microsynth, Balgach, Switzerland). Real-time PCR reactions were performed using 
TaqMan Universal PCR Master Mix (Applied Biosystems). Briefly, 3.5 µL cDNA, 1 µL of each 
primer (25 µM), 0.5 µL labelled probe (5 µM), 6.5 µL RNAse free water, 12.5 µL TaqMan 
Universal PCR Master Mix reached 25 µL of final reaction volume. Reaction conditions were 
denaturation at 95  ° C for 10 min followed by 40 cycles of denaturation at 95  ° C for 15 s and 
annealing/elongation at 60  ° C for 60 s with auto ramp time. All reactions were run in duplicate. 
For analysing the data, the threshold was set to 0.06 as this value had been determined to be 
in the linear range of the amplification curves for all mRNAs in all experimental runs. The 
expression of gene of interest was calculated in relation to hypoxanthine guanine phosphori-
bosyl transferase. Relative expression ratios were calculated as R = 2(Ct [hypoxanthine guanine phos-
phoribosyl transferase]) – Ct [test gene], where Ct represents the cycle number at the threshold 0.06.
Brush Border Membrane Vesicles Preparation
Mice were anaesthetized with ketamine-xylazine intraperitoneally and kidneys were 
removed and rapidly frozen in liquid nitrogen. Brush border membranes were prepared as 
described previously using the Mg2+-precipitation technique [8, 9] and further used for immu-
noblotting. Total membrane protein preparations were obtained as previously described 
[10]. Briefly, total kidneys were homogenized in an ice-cold K-HEPES buffer (200 mmol/L 
mannitol, 80 mmol/L K-HEPES, 41 mmol/L KOH, pH 7.5) with pepstatin, leupeptin, K-ethyl-
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enedi-aminetetraacetic acid, and phenylmethylsulfonyl fluoride added as protease inhibitors. 
The samples were centrifuged at 1,000 g for 10 min at 4  ° C and the supernatant saved. Subse-
quently, the supernatant was centrifuged at 100,000 g for 1 h at 4  ° C and the resultant pellet 
resuspended in K-HEPES buffer containing protease inhibitors.
Immunoblotting
After measurement of the protein concentration (Bio-Rad, Hercules, CA, USA), 10 µg of 
brush border membrane or 50 µg of total membrane proteins were solubilized in Laemmli 
sample buffer, and SDS-PAGE was performed on a 10% polyacrylamide gel. For immunob-
lotting, the proteins were transferred electrophoretically to polyvinylidene fluoride 
membranes (Immobilon-P, Millipore, Bedford, MA, USA). After blocking with 5% milk powder 
in Tris-buffered saline/0.1% Tween-20 for 60 min, the blots were incubated with the primary 
antibodies: rabbit anti-Octn1 1: 1,000 (#OCTN11-A, Alpha Diagnostics, San Antonio, TX, USA), 
rabbit anti-Urat-1 1: 1,000 [11], rabbit anti-Oat-1 (#OAT11-A, Alpha Diagnostics, San Antonio, 
TX, USA) 1: 200, and mouse monoclonal anti-β-actin antibody (42 kD; Sigma, St. Louis, MO, 
USA; 1: 5,000) either for 2 h at room temperature or overnight at 4  ° C. The membranes were 
then washed 3 times, blocked for 1 h, and again incubated for 1 h at room temperature with 
the secondary goat antirabbit or donkey antimouse antibodies 1: 5,000 linked to alkaline 
phosphatase (Promega, Madison, WI, USA). The protein signal was detected with the CDP Star 
chemilumescensce system (Roche Diagnostics, Basel, Switzerland) using the DIANA III-
chemiluminescence detection system (Raytest, Straubenhardt, Germany). All images were 
analyzed using appropriate software (Advanced Image Data Analyser AIDA, Raytest) to calculate the protein of interest/β-actin ratio.
Table 2. Metabolic cages and blood gas analysis






Urine, mean ± SD
pH 6.34±0.05 5.4±0.05*** 5.37±0.04*** 6.17±0.05
NH3/NH4
+, mM/crea, mg/dL 4.18±0.98 41.50±5.99** 38.89±7.72* 5.98±0.70
TA, mM/crea, mg/dL 0.095±0.02 0.073±0.005 0.071±0.004 0.091±0.004
NAE, mM/crea, mg/dL 4.10±0.86 41.43±5.99** 38.82±7.73* 5.89±0.70
Na+, mM/crea, mg/dL 15.3±2.9 11.5±0.9 12.8±0.7 7.0±1.6*
K+, mM/crea, mg/dL 36.6±8.7 27.0±2.6 29.6±1.7 35.6±7.3
Cl–, mM/crea, mg/dL 27.7±4.4 90.00±8.7*** 108.2±5.7*** 21.0±0.9
Uric acid, mM/crea, mg/dL 13.2±2.1 8.5±0.5 7.5±0.4 15.0±2.7
Blood, mean ± SD
pH 7.23±0.02 7.1±0.03* 7.22±0.03 7.20±0.03
pCO2 41.7±2.7 44.2±2.4 40.13±3.6 44.1±1.1
HCO3
–, mM 16.9±1.1 13.2±0.75* 14.5±1.7 16.8±1.1
Na+, mM 143.5±1.7 149.4±2.6 149.8±1.2* 148.4±0.7*
Cl–, mM 112.5±0.9 122.6±0.7*** 118.0±1.2* 116.0±0.5**
K+, mM 8.0±0.3 7.4±0.3 7.0±0.3 6.9±0.4
Uric acid, mg/dL 9.0±0.9 6.9±0.7 8.4±0.5 8.9±0.9
Body weight, g 25.7±0.5 26.5±0.4 24.9±0.3 25.3±0.3*
Blood gas and electrolytes in blood and urine from control mice and animals receiving NH4Cl for 2 or 7 
days, or 2% oxonic acid for 7 days, respectively. Five animals were analyzed for each group.
* p > 0.05, ** p > 0.01, *** p > 0.001 compared to control.
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Statistical Analysis
Results are expressed as mean ± SEM. All data were tested for significance using the 
ANOVA and unpaired Student test where appropriate. Only values with p < 0.05 were 
considered as significant. 
Results
Mice received 0.28 M NH4Cl for 2 or 7 days to induce metabolic acidosis as described 
previously [12–14]. One group of mice also received the uricase inhibitor oxonic acid (2%) in 
order to test whether increased urate availability had a similar influence as NH4Cl on the 
expression of the transporters of interest. All treatments had a similar impact on body weight 
and food intake as assessed in metabolic cages (Table 2). As expected, NH4Cl induced an acid 
load with metabolic acidosis after 2 days which was mostly compensated by day 7. Plasma 
uric acid was lower after 2 days of NH4Cl; however, the difference did not reach statistical 
significance. Urine uric acid excretion normalized to creatinine was lower in the animals 
receiving NH4Cl for 2 or 7 days. In contrast, animals receiving 2% oxonic acid showed no 
difference in their uric acid/creatinine ratio as compared to control animals (Fig. 1, Table 2). 
This may reflect adaption to a new steady state of uric acid production and elimination.
Next we assessed the impact of NH4Cl or oxonic acid on transporters whose expression 
had been found to be altered by NH4Cl treatment in mice for 2 or 7 days [12]. Where possible 
and antibodies available to us, we tested also on concomitant changes in protein abundance.
The mRNA abundance of Slc22a1, the Oct1, was transiently and significantly reduced by 
2 days of NH4Cl but returned to normal levels after 7 days of NH4Cl. Oxonic acid had no effect 
on Slc22a1 mRNA expression (Fig. 2). The protein expression levels of Oct1 could not be 
investigated as none of the antibodies tested by us appeared to be specific enough.
Plasma uric acid















































Fig. 1. Plasma and urine uric acid. 
Uric acid levels were measured in 
plasma samples and in 24 h urine 
collections from control mice, 
mice receiving NH4Cl for 2 or 7 
days, and mice receiving 2% ox-
onic acid. n = 5/group.
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NH4Cl significantly increased the mRNA abundance of the  Octn1 (Slc22a4) both after 2 
and 7 days. Similarly, Octn1 protein abundance was higher after 7 days of NH4Cl. Oxonic acid 
did not modulate Slc22a4 mRNA or protein abundance (Fig. 3).
Induction of acidosis also changed the mRNA and protein expression of the Oat1 
(Slc22a6; Fig. 4). NH4Cl transiently but significantly reduced both mRNA and protein abun-
dance after 2 days, whereas after 7 days mRNA and protein expression levels had returned 
Slc22a1 - OCT1






















Fig. 2. Expression of the Oct1 in 
mouse kidney. Semi-quantitative 
RT-PCR was performed on total 
mRNA extracted from kidneys 
from control mice, mice receiving 
NH4Cl for 2 or 7 days, and mice re-
ceiving 2% oxonic acid. n = 5/
group, * p < 0.05. OCT, organic cat-
ion transporter; SLC22, solute 
carrier family 22.
Slc22a4 - OCTN1


























































Fig. 3. Regulation of the Octn1 
cation transporter in mouse kid-
ney. Semi-quantitative RT-PCR 
was performed on total mRNA 
and immunoblotting on brush 
border membranes extracted 
from kidneys from control mice, 
mice receiving NH4Cl for 2 or 7 
days, and mice receiving 2% ox-
onic acid. Membranes were stripped and reprobed for β-actin 
to control for loading. Bar graphs 
show Octn1 protein abundance normalized to β-actin and ex-
pressed as percentage of the con-
trol group. n = 5/group, * p < 0.05, 
** p < 0.01, *** p < 0.001. OCT, or-
ganic cation transporter; SLC22, 
solute carrier family 22.
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Slc22a6 - OAT1





















































Fig. 4. Regulation of the Oat1 anion transporter in mouse kidney. Semi-quantitative RT-PCR was performed 
on total mRNA and immunoblotting on total membranes extracted from kidneys from control mice, mice re-
ceiving NH4Cl for 2 or 7 days, and mice receiving 2% oxonic acid. Membranes were stripped and reprobed for β-actin to control for loading. Bar graphs show Oat1 protein abundance normalized to β-actin and ex-
pressed as percentage of the control group. n = 5/ group, * p < 0.05, ** p < 0.01. OCT, organic cation trans-
porter; SLC22, solute carrier family 22.
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to baseline. Oxonic acid increased Slc22a4 mRNA abundance; however, this effect was not 
seen on protein levels.
NH4Cl and oxonic acid decreased Slc22a19 (Oat5) mRNA expression (Fig. 5), the effects 
on protein abundance could not be tested due to lack of specific antibodies.
Last, we assessed the effects of NH4Cl and oxonic acid on the expression of the Urat1 urate 
transporter (Fig. 6). While 2 days of NH4Cl decreased and 7 days of oxonic acid increased 
Slc22a19 - OAT5





















Fig. 5. Expression of the OAT5 in 
mouse kidney. Semi-quantitative 
RT-PCR was performed on total 
mRNA extracted from kidneys 
from control mice, mice receiving 
NH4Cl for 2 or 7 days, and mice re-
ceiving 2% oxonic acid. n = 5/ 
group, * p < 0.05, ** p < 0.01. OCT, 
organic cation transporter; SLC22, 























































Fig. 6. Regulation of the Urat1 
urate transporter in mouse kid-
ney. Semi-quantitative RT-PCR 
was performed on total mRNA 
and immunoblotting on brush 
border membranes extracted 
from kidneys from control mice, 
mice receiving NH4Cl for 2 or 7 
days, and mice receiving 2% ox-
onic acid. Membranes were stripped and reprobed for β-actin 
to control for loading. Bar graphs 
show Urat1 protein abundance normalized to β-actin and ex-
pressed as percentage of the con-
trol group. n = 5/group, * p < 0.05, 
** p < 0.01, *** p < 0.001. SLC22, 
solute carrier family 22.
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Slc22a12 mRNA expression levels, 2 days of NH4Cl slightly increased and 7 days of NH4Cl 
strongly decreased Urat1 protein abundance. Oxonic acid had no apparent effect on Urat1 
protein expression levels.
Discussion
The kidneys have a central role in the elimination of water-soluble endogenous and exog-
enous waste products and drugs. Members of the Slc22 family of anion and cation trans-
porters play a critical role in this process. Their activity is regulated by various factors 
including hormones, metabolites, and also gut microbiome-derived signals [2, 15–17] Here 
we provide additional evidence for regulation by systemic acid-base status. Our data provide 
evidence for the acute and partly transient regulation of several members of the Slc22 family 
during metabolic acidosis.
We show here that the apical Octn1 transporter is upregulated during chronic metabolic 
acidosis on protein level. This is preceded and paralleled by increased mRNA abundance of 
this transporter. Protein expression of the basolateral Oat1 transporter is transiently reduced 
during acute (2 days) metabolic acidosis but returns to baseline after 7 days acidosis. Also 
this is paralleled by similar mRNA abundance of Oat1. Also Urat1 showed the same course of 
protein and mRNA expression with a transient reduction after 2 days metabolic acidosis. In 
case of the Oct1 and Oat5 transporters only mRNA levels could be examined and both showed 
lower mRNA abundance during the acute phase of metabolic acidosis. Oct1 mRNA returned 
to baseline, whereas Oat5 remained lower with more prolonged acidosis. Inhibition of uricase 
activity with oxonic acid had surprisingly no effect on plasma uric acid levels and reduced 24 
h uric acid excretion. Oxonic acid had no effect on Oct1 mRNA, Octn1 mRNA, and protein 
levels but increased Urat1 and Oat1 mRNA levels (without altering URAT1 protein levels) and 
lowered Oat5 mRNA abundance. Thus, reduced urinary uric acid excretion is not paralleled 
by changes in the abundance of the URAT1 transporter.
Changes in mRNA and protein expression of the Slc22 transporters investigated did not 
always parallel [3]. This was particularly obvious for URAT1. Different processes regulate 
transcription and translation and metabolic acidosis has been shown to impact on both 
processes through modulation of transcription factors as well as by altering translation or 
posttranslational modifications [18, 19]. In case of Slc22 transporters, the correlation between 
mRNA or protein expression and ultimate activity in proximal tubular cells may be even more 
difficult as the functional activity of several members of the this transporter family is highly 
regulated by a complex network of kinases altering transport activity within minutes 
presumably without affecting protein abundance [15]. Whether acidosis impacts on these 
signaling cascades and their ability to regulate Slc22 transporters remains to be investigated.
Our results confirm and extend data from a previous report that showed an acute acid 
load (comparable to our 2 days metabolic acidosis) caused downregulation of Oat3 protein 
(not tested here) and did not affect Oat1 and Oct2 protein levels. We had not tested for Oat1 
protein abundance and Oct2 had not been included in our panel of transporters tested as it 
had not been regulated on mRNA levels in our previous genome wide screen for renal tran-
scripts altered during metabolic acidosis [3]. However, Gaowa et al. [4] demonstrate that 
metabolic acidosis has a relevant impact on plasma levels of 2 substances that are at least in 
part eliminated by members of the Slc22 family, metformin and phenolsulfonphthalein. 
Phenolsulfonphthalein and metformin levels in plasma were elevated after 2 days of meta-
bolic acidosis indicating reduced active secretion consistent with downregulation of Slc22 
transporters [3]. Thus, metabolic acidosis has a relevant impact on Slc22 transporter mediated 
drug and metabolite clearance.
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Some members of the Slc22 transporter family such as Oat1 and 3 couple the transport of drugs or metabolites to the exchange against α-ketoglutarate [2, 20]. Transport of a-keto-
glutrate is also coupled via the TCA cycle to cellular lactate levels [21]. Of note, the urinary excretion of α-ketoglutarate and lactate as well as the expression of several lactate trans-
porters from the Slc5 and 16 monocarboxylate transporter families is also affected by meta-
bolic acidosis [22, 23]. It is thus conceivable that the effect of acidosis on the ability of the 
proximal tubule to secrete drugs and metabolites involves not only downregulation of Slc22 
drug transporters but also transporters and metabolic pathways that provide substrate for 
obligatory exchange via Oat transporters.
In summary, we demonstrate that the expression levels of several renal proximal tubular 
transporters are altered during metabolic acidosis. This is consistent with changes also in metab-
olites transported by some of these transporters as well as with altered pharmacokinetics of 
prototypical substrates of these transporters. Thus, acid-base status may be a relevant factor 
affecting pharmacokinetics of drugs eliminated by transporters sensitive to acid-base status.
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